Cardiff Oncology
Alissa Sheldon is a Senior Clinical Trial Manager at Cardiff Oncology, specializing in mCRC and PDAC since May 2022. Prior to this role, Alissa served as a Sr. Clinical Team Manager at PRA Health Sciences from March 2021 to May 2022, where responsibilities included global leadership for clinical trials in NSCLC, CRC, and PDAC across phases I-III. Alissa's extensive experience also includes positions such as Clinical Lead at Syneos Health and various roles at ICON plc, Parexel, and Biotronik, focusing on clinical data analysis and research. Alissa's educational background consists of a Bachelor's degree in Psychology and Sociology from Oregon State University and a Post-Baccalaureate in Pre-med from Portland State University.
This person is not in any offices
Cardiff Oncology
Cardiff Oncology is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Our goal is to overcome resistance, improve response to treatment and increase overall survival. We are developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.